Listed

Altimmune, Inc.

ALTNasdaqCIK 1326190HealthcareFiscal year ends Dec 31

All transactions: 15

Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.

What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

Altimmune, Inc., insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2018-09-12Novartis Bioventures Ltd10% ownerOther2,069,993not reportednot reportedForm 4
2018-07-11Novartis Bioventures Ltd10% ownerOther663,346not reportednot reportedForm 4
2018-06-15Novartis Bioventures Ltd10% ownerOther14,449not reportednot reportedForm 4
2018-06-13Novartis Bioventures Ltd10% ownerOther720,878not reportednot reportedForm 4
2018-05-16Novartis Bioventures Ltd10% ownerOther767,728not reportednot reportedForm 4
2018-05-15Novartis Bioventures Ltd10% ownerOther274,703not reportednot reportedForm 4
2018-04-16Novartis Bioventures Ltd10% ownerOther217,159not reportednot reportedForm 4
2018-04-16Novartis Bioventures Ltd10% ownerOther482,907not reportednot reportedForm 4
2018-03-15Novartis Bioventures Ltd10% ownerOther261,969not reportednot reportedForm 4
2018-02-15Novartis Bioventures Ltd10% ownerOther67,925not reportednot reportedForm 4
2018-02-13Novartis Bioventures Ltd10% ownerOther269,527not reportednot reportedForm 4
2018-01-17Novartis Bioventures Ltd10% ownerOther176,586not reportednot reportedForm 4
2017-12-15Novartis Bioventures Ltd10% ownerOther65,718not reportednot reportedForm 4
2017-12-13Novartis Bioventures Ltd10% ownerOther242,694not reportednot reportedForm 4
2017-11-14Novartis Bioventures Ltd10% ownerOther182,262not reportednot reportedForm 4

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 07:04 ET. Listed shows no prices and gives no investment advice.